Bharat Rasayan Ltd
NSE: BHARATRAS BSE: 590021Chemicals
Bharat Rasayan Ltd is engaged in manufacturing Technical Grade Pesticides and Intermediates used in the agro-chemical industry. It was incorporated in 1989.[1]
₹1,376
52W: ₹1202 — ₹3030
PE 16.1 · Book ₹707 · +95% vs bookMarket Cap₹2,288 Cr
Stock P/E16.1Price to Earnings
ROCE14.3%Return on Capital
ROE11.1%Return on Equity
Div. Yield0.03%Face Value ₹5
Strengths
- +Company is almost debt free.
Weaknesses
- −The company has delivered a poor sales growth of -0.71% over past five years.
- −Company has a low return on equity of 11.6% over last 3 years.
- −Dividend payout has been low at 0.58% of profits over last 3 years
Shareholding Pattern
Promoters74.99%
FIIs0.54%
DIIs2.14%
Public22.33%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% |
| FIIs | 0.35% | 0.46%▲0.1 | 0.45%▼0.0 | 0.49%▲0.0 | 0.56%▲0.1 | 0.47%▼0.1 | 0.43%▼0.0 | 0.54%▲0.1 |
| DIIs | 2.59% | 2.64%▲0.1 | 2.6%▼0.0 | 2.75%▲0.1 | 2.74%▼0.0 | 2.75%▲0.0 | 2.52%▼0.2 | 2.14%▼0.4 |
| Public | 22.07% | 21.9%▼0.2 | 21.96%▲0.1 | 21.77%▼0.2 | 21.71%▼0.1 | 21.79%▲0.1 | 22.05%▲0.3 | 22.33%▲0.3 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 263 | 233 | 310 | 282 | 328 | 256 | 307 | 377 | 286 | 270 |
| Expenses | 248 | 205 | 240 | 244 | 273 | 215 | 266 | 304 | 253 | 228 |
| Operating Profit | 15 | 28 | 69 | 38 | 55 | 42 | 40 | 73 | 33 | 43 |
| OPM % | 6% | 12% | 22% | 14% | 17% | 16% | 13% | 19% | 12% | 16% |
| Net Profit | 8 | 17 | 56 | 27 | 40 | 30 | 28 | 44 | 26 | 34 |
| EPS ₹ | 4.63 | 10.41 | 33.68 | 16.14 | 24.19 | 17.89 | 17.14 | 26.3 | 15.76 | 20.45 |
AI Insights
Revenue Trend
TTM revenue at ₹1,240Cr, up 5.9% YoY. OPM at 15%.
Debt Position
Borrowings at ₹90Cr. Debt-to-equity ratio: 0.08x. Healthy balance sheet.
Capex Cycle
CWIP at ₹25Cr (11% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 2.14% (-0.43pp change). FIIs: 0.54% (+0.19pp change). Promoters hold 74.99%.
Margin & Efficiency
ROCE declining from 22% (Mar 2014) to 14% (Mar 2025). Working capital days: 170.
Valuation
PE 16.1x with 14.3% ROCE. Price is 95% above book value of ₹707. Dividend yield: 0.03%.
Recent Announcements
- Board Meeting Intimation for Results & Closure of Trading Window 9 May
- Closure of Trading Window 23 Mar
- Standalone & Consolidated Financial Results, Limited Review Report for December 31, 2025 13 Feb
- Board Meeting Intimation for Results & Closure of Trading Window 30 Jan - Board meeting on 12 Feb 2026 to approve Q3/9M results; trading window closed Jan30–Feb14.
- Clarification sought from Bharat Rasayan Ltd 27 Jan - Exchange has sought clarification from Bharat Rasayan Ltd on January 27, 2026 with reference to significant movement in price, in order to ensure that investors …
- Financial Year 2024 from bse
- Financial Year 2023 from bse
- Financial Year 2022 from bse